v3.25.4
Condensed Consolidated Interim Balance Sheets - USD ($)
Dec. 31, 2025
Mar. 31, 2025
CURRENT ASSETS    
Cash $ 256,357 $ 365,145
Accounts receivable, net 1,578,269 1,658,772
Inventory [Note 3] 1,974,758 1,555,385
Deposits and other receivables 1,171,855 1,059,990
Total current assets 4,981,239 4,639,292
Deposits and other receivables 109,297 109,297
Long-term accounts receivable 122,398 70,713
Property and equipment [Note 12] 5,134 9,599
Operating right of use assets [Note 10] 468,427 812,053
TOTAL ASSETS 5,686,495 5,640,954
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 8,532,932 7,661,924
Convertible promissory notes and short term loans [Note 5] 11,145,852 9,618,738
Term loan, current [Note 6] 2,400,000 2,400,000
Derivative liabilities [Note 8] 432,782 424,200
Advance from customers 745,920
Operating lease obligations, current [Note 10] 539,398 531,286
Total current liabilities 23,796,884 20,636,148
Federally guaranteed loans [Note 7] 870,800 870,800
Term loan [Note 6] 12,130,104 12,271,559
Derivative liabilities [Note 8] 1,410,976 1,478,717
Operating lease obligations [Note 10] 397,830
TOTAL LIABILITIES 38,208,764 35,655,054
Mezzanine Equity    
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 335 and 385 shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively [Note 9] 1,714,476 2,000,290
STOCKHOLDERS’ (DEFICIENCY)    
Series A Preferred Stock, $0.001 par value, 20,000 shares authorized as at December 31, 2025 and March 31, 2025, respectively, 201 preferred shares issued and outstanding as at December 31, 2025 and March 31, 2025, [Note 9] 1 1
Common stock, $0.001 par value, 125,000,000 shares authorized as at December 31, 2025 and March 31, 2025, respectively. Issued and outstanding common shares: 27,807,711 and 26,081,295 as at December 31, 2025 and March 31, 2025, respectively, and exchangeable shares of 160,672 outstanding as at December 31, 2025 and March 31, 2025, respectively [Note 9] 27,969 26,243
Shares to be issued 581,599 and 581,599 shares of common stock as at December 31, 2025 and March 31, 2025, respectively [Note 9] 284,244 284,244
Additional paid-in-capital 107,615,332 107,123,300
Accumulated other comprehensive loss (47,823) (6,393)
Accumulated deficit (142,116,468) (139,441,785)
Total stockholders’ (deficiency) (34,236,745) (32,014,390)
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
Series A Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Series A Preferred Stock, $0.001 par value, 20,000 shares authorized as at December 31, 2025 and March 31, 2025, respectively, 201 preferred shares issued and outstanding as at December 31, 2025 and March 31, 2025, [Note 9]